QuikClot
QuikClot is a
History
The use of a sterilized molecular sieve material, such as zeolite, in a binding material to treat wounds was patented by Frank Hursey in 1989.[2] Following the September 11 attacks, the US armed forces conducted a study comparing different antihemorrhagic technologies, in which QuikClot received the best score.[3] Another study found that when used to treat lethal groin injuries in swine, the treated animals had a 100% survival rate.[4] Following these tests, the US armed forces approved its use in Afghanistan and Iraq.[citation needed]
Zeolite
The original formulation of the product contained the active ingredient
Kaolin
By 2009, QuikClot devices were made of gauze impregnated with
Mechanism
QuikClot was originally available as a
The Kaolin in QuikClot Interventional bandages absorb the water molecules in blood, leaving behind the relatively bigger
Use by the US military
In the Tactical Combat Casualty Care Guidelines published by the CoTCCC (Committee on Tactical Combat Casualty Care) in 2014, QuikClot Combat Gauze was listed as the ideal hemostatic dressing to be used for external hemorrhage not amenable to tourniquet use or as an adjunct to tourniquet removal if evacuation time is anticipated to be longer than 2 hours.[10] In the TCCC Guidelines published in 2021, Combat Gauze remained the choice hemostatic dressing for such an injury.[11]
References
- ^ Quickclot. About Teleflex
- ^ US patent 4822349, Francis X. Hursey & Fernand J. Dechene, "Method of treating wounds", published 1989-04-18, issued 1989-04-18
- .
- .
- .
- FDA. p. 1. Retrieved 26 April 2023.
The hemostatic pad is a hemostatic dressing made of soft, white, kaolin impregnated gauze, configured in a 1½" long by 1½" wide by ½" thick multi-layer pad.
- .
- hdl:11380/649198.
- ISBN 9780471253945.
- ^ "Tactical Combat Casualty Care Guidelines" (PDF). 2 June 2014. Archived from the original (PDF) on 23 June 2015. Retrieved 25 March 2015.
- .